127 related articles for article (PubMed ID: 8232486)
21. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
Safrin S; Kemmerly S; Plotkin B; Smith T; Weissbach N; De Veranez D; Phan LD; Cohn D
J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
[TBL] [Abstract][Full Text] [Related]
22. [Cutaneomucosal herpes in immunocompetent pregnant women].
Lecat M
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):523-32. PubMed ID: 12122322
[TBL] [Abstract][Full Text] [Related]
23. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
25. Detection of a novel mutation conferring acyclovir resistance and consecutive treatment failure in an HIV-positive patient with recurrent HSV-2 infection.
Schleenvoigt BT; Pletz MW; Deinhardt-Emmer S; Sauerbrei A
J Glob Antimicrob Resist; 2018 Mar; 12():20. PubMed ID: 29179992
[No Abstract] [Full Text] [Related]
26. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
27. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
[TBL] [Abstract][Full Text] [Related]
28. Painful genital ulcers.
Usatine RP
J Fam Pract; 2003 Dec; 52(12):951-4. PubMed ID: 14653981
[No Abstract] [Full Text] [Related]
29. Medical management of genital herpes. Advances in antiviral treatment.
Marlowe SI
Arch Dermatol; 1985 Apr; 121(4):467-70. PubMed ID: 4038863
[No Abstract] [Full Text] [Related]
30. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
31. Genital herpes simplex virus infections in adults.
Mertz G; Corey L
Urol Clin North Am; 1984 Feb; 11(1):103-19. PubMed ID: 6369699
[TBL] [Abstract][Full Text] [Related]
32. Genital herpes: oral treatment with acyclovir.
Ruhnek-Forsbeck M
Scand J Infect Dis Suppl; 1985; 47():63-6. PubMed ID: 3912973
[TBL] [Abstract][Full Text] [Related]
33. [Genital herpes in immunocompetent men and non-pregnant women Clinical aspects, accuracy of clinical examination, evolution].
Janier M
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):586-96. PubMed ID: 12122328
[TBL] [Abstract][Full Text] [Related]
34. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
[TBL] [Abstract][Full Text] [Related]
35. Acyclovir for genital herpes simplex virus infections. A review.
Baker DA; Milch PO
J Reprod Med; 1986 May; 31(5 Suppl):433-8. PubMed ID: 3522895
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
37. A trial of topical acyclovir in genital herpes simplex virus infections.
Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
[TBL] [Abstract][Full Text] [Related]
38. The role of oral acyclovir in the management of genital herpes simplex.
Sacks SL
CMAJ; 1987 Apr; 136(7):701-7. PubMed ID: 3548933
[TBL] [Abstract][Full Text] [Related]
39. Suppression of recurrent genital herpes with oral acyclovir.
Straus SE; Seidlin M; Takiff HE; Bachrach S; DiGiovanna JJ; Western KA; Creagh-Kirk T; Lininger L; Alling DW
Trans Assoc Am Physicians; 1983; 96():278-83. PubMed ID: 6388102
[No Abstract] [Full Text] [Related]
40. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
